High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients-Reference-Cited by-同舟云学术

High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients

Published:2005-05-01 Issue:1 Volume:39 Page:23-31
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Ostrowski Sisse Rye,Piironen Timo,Høyer-Hansen Gunilla,Gerstoft Jan,Pedersen Bente Klarlund,Ullum Henrik

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference60 articles.

1. Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.;Ostrowski;J Acquir Immune Defic Syndr,2004

2. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.;Sidenius;Blood,2000

3. The urokinase receptor.;Behrendt;Fibrinolysis Proteolysis,1998

4. Urokinase receptor. An activation antigen in human T lymphocytes.;Nykjaer;J Immunol,1994

5. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells.;Nykjaer;FEBS Lett,1992

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. suPAR in cardiovascular disease;Advances in Clinical Chemistry;2024

2. suPAR to Risk-Stratify Patients With Malaria;Frontiers in Immunology;2022-06-10

3. Soluble Urokinase-Type Plasminogen Activator Receptor as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria;Clinical Infectious Diseases;2022-06-07

4. Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy;Journal of Clinical Medicine;2022-05-16

5. Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor;Journal of Personalized Medicine;2022-03-14